GEN Exclusives

More »

GEN News Highlights

More »
Jun 20, 2007

RFS Pharma and Genoscience to Jointly Work on Protease Inhibitors for Viral Infections

  • RFS Pharma and Genoscience Pharma formed a drug discovery joint venture to develop protease inhibitors for the treatment of life-threatening viral infections.

    The companies will collaborate on the discovery, optimization, and development of lead compounds into therapeutic agents. Genoscience’s molecular modeling capabilities will be coupled with RFS Pharma’s expertise in pharmacology and drug development.

    "This strategic alliance expands the breath of our company beyond our expertise in nucleoside analogs," explains Raymond F. Schinazi, founder and executive director of RFS Pharma. “Genoscience also provides RFS Pharma with a presence in Europe for further expansion.”



Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

Be sure to take the GEN Poll

Cancer Drug Approvals and Efficacy

Do you think regulatory agencies should be required to provide stronger evidence of the clinical effectiveness of cancer drugs, including a greater emphasis on patient survival time?

More »